Genetic Testing Market On Position to Cross $17,607 Million by 2025

Genetic Testing Market is projected to reach $17,607 million by 2025, growing at a CAGR of 11.3% from 2018 to 2025. The diagnostic testing segment accounted around half of the total market share in 2017.

Genetic testing is the study of genes that examines genetic material taken from cells in a persons blood sample or a sample of other body fluids. The study is conducted in relation to hereditary and variations in genes and number of chromosomes, which are used for the detection of genetic disorders as well as selection of precise therapies for the treatment of these genetic disorders. Genetic testing includes various techniques such as comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, immunohistochemistry, and others.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/5241

The global genetic testing market is expected to register substantial growth in the near future due to rise in incidence of genetic disorders & cancer. In addition, growing demand for personalized medicine and increasing application of genetic testing in oncology are expected to boost the market growth during the forecast period. However, high costs of genetic testing and stringent regulatory requirements for product approvals are anticipated to hamper the genetic testing market growth during the forecast period. Conversely, untapped emerging markets in developing countries are expected to provide remunerative opportunities for the market players. Therefore, these drivers and opportunities are anticipated to boost the global genetic testing market share.

The report provides a comprehensive analysis of the key players operating in the global genetic testing market, namely Abbott Laboratories, Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Myriad Genetics, Inc. (Myriad RBM, Inc.), Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd., Eurofins Scientific, Illumina, Inc., Qiagen N.V., Novartis International AG, and Thermo Fisher Scientific, Inc. The other players operating in the genetic testing industry include Agilent Technologies, Inc., Empire Genomics, LLC, Irvine Scientific, PerkinElmer, Inc., Sysmex Corporation, and others.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5241

Key Findings of the Genetic Testing Market:

o Based on technology, the biochemical testing segment is expected to experience rapid growth in the market and is projected to grow at a CAGR of 12.0% from 2018 to 2025.
o Depending on application, the genetic diseases diagnosis segment holds the highest revenue in 2017 and is expected to maintain its dominance during the forecast period.
o U.S. generated the highest revenue in the global genetic testing market in 2017, accounting around two-fifth of the global market in 2017.
o Asia-Pacific is estimated to grow at a CAGR of 13.0% during the forecast period.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.